Plus Therapeutics (PSTV) Times Interest Earned (2011 - 2026)
Plus Therapeutics (PSTV) reported Times Interest Earned of -$418.76 for Q1 2026, down 6389.91% year-over-year from $6.66 in Q1 2025, and down 6389.91% quarter-over-quarter from -$6.45 in Q1 2025.
Plus Therapeutics (PSTV) Times Interest Earned (2011 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has 16 years of Times Interest Earned data on file, last reported at -$418.76 in Q1 2026.
- Times Interest Earned for Q1 2026 came in at -$418.76, down 6389.91% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1110.6 (down 5054.56% YoY), and the FY2025 annual result was -$27.92, up 66.0% from the prior year.
- Times Interest Earned declined to -$418.76 in Q1 2026 per PSTV's latest filing, from -$6.45 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$6.45 in Q1 2025 and troughed at -$418.76 in Q1 2026.
- A 5-year average of -$75.84 and a median of -$43.78 in 2022 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2025 and 2026: Times Interest Earned jumped 93.35% in 2025, then slumped 6389.91% in 2026.
- A 5-year view of Times Interest Earned shows it stood at -$50.2 in 2022, then declined by 23.96% to -$62.23 in 2023, then fell by 9.96% to -$68.42 in 2024, then soared by 90.57% to -$6.45 in 2025, then tumbled by 6389.91% to -$418.76 in 2026.
- Business Quant data shows PSTV's Times Interest Earned at -$418.76 in Q1 2026, -$6.45 in Q1 2025, and -$68.42 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -258.33 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 11.79 |
| 10 | Plus Therapeutics | 37.48 Mn | 22.37 Mn | - | -418.76 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -418.76 |
| Mar 31, 2025 | -6.45 |
| Dec 31, 2024 | -68.42 |
| Sep 30, 2024 | -62.28 |
| Jun 30, 2024 | -136.93 |
| Mar 31, 2024 | -97.03 |
| Dec 31, 2023 | -62.23 |
| Sep 30, 2023 | -37.37 |
| Jun 30, 2023 | -13.30 |
| Mar 31, 2023 | -35.24 |
| Dec 31, 2022 | -50.20 |
| Sep 30, 2022 | -25.47 |
| Jun 30, 2022 | -28.29 |
| Mar 31, 2022 | -19.83 |
| Dec 31, 2021 | -20.52 |
| Sep 30, 2021 | -17.50 |
| Jun 30, 2021 | -12.88 |
| Mar 31, 2021 | -10.04 |
| Dec 31, 2020 | -16.98 |
| Sep 30, 2020 | -4.65 |